EUVIMEDEUVIMED entdecken
Open Access

Engineering NIR Probes to Enhance Affinity and Clinical Workflow Compatibility for Prostate Cancer Imaging

Gauri S Malankar, Dani A Szafran, Gourav Kumar, Joshua Pace, Mackenzie Devereux, Kai Tao, Michelle Gomes, William S Greer, Cody C Rounds, Anas M Masillati, Seseel Gergis, Hayden Ledvina und 5 weitere

Angewandte Chemie International Edition · 2026

DOI: 10.1002/anie.202520355 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Angewandte Chemie International Edition, 2026. Verfasst von Gauri S Malankar und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, 97201, USA. Hauptthemen laut MEDLINE: Prostatic Neoplasms, Fluorescent Dyes, Optical Imaging. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NCI NIH HHS, OHSU Foundation, Kuni Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Positive surgical margins following radical prostatectomy increase the risk of biochemical recurrence and subsequent disease progression. Fluorescence‐guided surgery (FGS) using targeted contrast agents has shown clinical benefits for several cancer types. However, current prostate cancer targeted imaging probes exhibit long pharmacokinetic (PK) profiles, necessitating extended waiting periods or repeated hospital visits, limiting their integration into standard clinical workflow. To overcome this critical clinical compatibility challenge, we developed an innovative tri‐compartment, chemistry‐driven probe design strategy. Specifically, we developed a congeneric library of near infrared (NIR) water soluble fluorescent probes incorporating: 1) a glutamic acid‐urea‐lysine (EuK) ligand targeting prostate specific membrane antigen (PSMA); 2) a NIR heptamethine cyanine fluorophore optimized for enhanced PSMA binding via secondary binding site interactions; and 3) distinct PK modulators residing outside the PSMA binding pocket to promote rapid off‐target tissue clearance. While molecular docking scores, photophysical properties and live‐cell staining results showed similar overall performance, probes bearing PK modulators produced stronger tumor‐specific fluorescence and accumulation in vivo than the control probe lacking a PK modulator. This effort enabled identification of a lead probe with robust tumor targeting and accelerated off‐target clearance, providing optimal tumor‐specific signal and contrast in a timeframe, fully compatible with robotic‐assisted radical prostatectomy (RARP) timelines.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Prostatic NeoplasmsFluorescent DyesOptical ImagingMaleHumansAnimalsUreaCarbocyaninesMolecular Docking SimulationGlutamic AcidGlutamate Carboxypeptidase IILysineInfrared Rays

Stichwörter der Autor:innen

Fluorescence‐guided surgery (FGS)Fluorescent probeNear Infrared (NIR) imagingPharmacokinetic modulationProstate cancer

Substanzen

Fluorescent DyesUreaCarbocyaninesGlutamic AcidGlutamate Carboxypeptidase IILysine

Autor:innen und Institutionen

  • Department Biomedical Engineering, Oregon Health & Science University, Portland, Oregon, 97201, USA.
  • Cancer Early Detection Advanced Research Center, Oregon Health & Science University, Portland, Oregon, 97201, USA.
  • Knight Cancer Institute, Oregon Health & Science University, Portland, Oregon, 97201, USA.
  • Department of Cell, Developmental and Cancer Biology, Oregon Health & Science University, Portland, Oregon, 97201, USA.
  • Department of Bioengineering, Northeastern University, Boston, Massachusetts, 02115, USA.

ORCID-Profile: Lei G Wang

Förderung

  • NCI NIH HHS
  • OHSU Foundation
  • Kuni Foundation
  • National Cancer Institute

Zitieren

APA

Malankar, G. S., Szafran, D. A., Kumar, G., Pace, J., Devereux, M., Tao, K., Gomes, M., Greer, W. S., Rounds, C. C., Masillati, A. M., Gergis, S., Ledvina, H., Milnes, K. J., Wong, M. H., Niedre, M. J., Gibbs, S. L., & Wang, L. G. (2026). Engineering NIR Probes to Enhance Affinity and Clinical Workflow Compatibility for Prostate Cancer Imaging. Angewandte Chemie International Edition. https://doi.org/10.1002/anie.202520355

Vancouver

Malankar GS, Szafran DA, Kumar G, Pace J, Devereux M, Tao K, et al. Engineering NIR Probes to Enhance Affinity and Clinical Workflow Compatibility for Prostate Cancer Imaging. Angewandte Chemie International Edition. 2026. doi:10.1002/anie.202520355

BibTeX
@article{Malankar2026,
  author = {Malankar, Gauri S and Szafran, Dani A and Kumar, Gourav and Pace, Joshua and Devereux, Mackenzie and Tao, Kai and Gomes, Michelle and Greer, William S and Rounds, Cody C and Masillati, Anas M and Gergis, Seseel and Ledvina, Hayden and Milnes, Kyle J and Wong, Melissa H and Niedre, Mark J and Gibbs, Summer L and Wang, Lei G},
  title = {Engineering NIR Probes to Enhance Affinity and Clinical Workflow Compatibility for Prostate Cancer Imaging},
  journal = {Angewandte Chemie International Edition},
  year = {2026},
  doi = {10.1002/anie.202520355}
}
Kostenlos starten →